Can AI help better predict mouth cancer risk? UK scientists think so London, Nov 5 (PTI) Artificial intelligence (AI) may help doctors better predict the risk of patients developing oral cancer by ensuring accuracy, consistency and objectivity, according to researchers from the University of Sheffield in the UK. The researchers are examining the use of […]
Read More
Artificial intelligence helps better predict mouth cancer risk Oral cancer is often detected late which means that the patient survival rates are poor. (Subscribe to Science For All, our weekly newsletter, where we aim to take the jargon out of science and put the fun in. Click here.) Artificial intelligence (AI) may help doctors […]
Read More
Cancer treatment during COVID-19: How to move ahead safely Cancer treatment during COVID-19: How to move ahead safely For many, cancer treatment is proceeding as usual during the pandemic. If you’re concerned, here are some things to discuss with your doctor. For many people diagnosed with cancer, treatment is carrying on as usual, despite the […]
Read More
Active Biotech Interim report January – September 2020 IMPORTANT EVENTS DURING THE THIRD QUARTERTasquinimod First patient dosed in the monotherapy part of the phase 1b/2a study in multiple myeloma The clinical study design for multiple myeloma will be presented at the virtual American Society of Hematology meeting 2020 in December Patents regarding treatment of acute […]
Read More Active Biotech announces rights issue NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW Active Biotech […]
Read More
Many volunteers world-wide commit themselves to raising funds for cancer research and cancer charities. Many hundreds of thousands more work in the industry as carers, or researching, prescribing, diagnosing and manufacturing drugs. Huge companies spend fortunes on cancer research. After so long and so many billions spent what exactly has cancer research revealed? There have […]
Read More
Adult onslaught Still’s disease is an incendiary circumstance that attacks domestic organs, joints and new parts of the system. It can seem and vanish abruptly. Though uncommon, it is establish global and predominantly affects inexperienced adults between 16 and 35. Still’s disease that occurs in children is called systemic juvenile idiopathic arthritis. Pregnant women are […]
Read More
Biomarkers that are predictive of clinical benefit in Trop-2-expressing triple-negative breast cancer Reviewed by Emily Henderson, B.Sc.Nov 3 2020 Oncotarget recently published “Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer” which reported that the authors investigated whether Trop-2-expression and homologous recombination repair of SN-38-mediated double-strand DNA breaks play a role in the […]
Read More
Dr Reddy’s gets nod for phase-3 Covid trials of cancer drug NEW DELHI: Dr Reddy’s Laboratories has won approval to conduct phase-3 clinical trials of a potential cancer drug that showed efficacy in Covid-19 patients during phase-2 trials. The subject expert committee, which advises the Drug Controller General of India on applications seeking approvals for […]
Read More
Understanding what to know about lung cancer [unable to retrieve full-text content] Risk of lung cancer is 15 to 30 times greater in smokers rather than non-smokers. Smoking is not the only culprit behind lung cancer, though. The CDC …Published at Wed, 04 Nov 2020 03:45:00 +0000
Read More